Antiretroviral resistance testing in people living with HIV

Hannah Green, Diana M Gibb, Abdel G Babiker, Janet H Darbyshire, David T Dunn, Ian V D Weller, HIV drug resistance testing: is the evidence really there? Antiviral Therapy. ,vol. 9, pp. 641- 648 ,(2004)

Richard M W Hoetelmans, Vanitha Sekar, David Back, Darunavir: pharmacokinetics and drug interactions. Antiviral Therapy. ,vol. 13, pp. 1- 13 ,(2008)

Dimitrios Paraskevis, Mario Poljak, Anne-Mieke Vandamme, Lucia Palmisano, Ricardo J Camacho, Vincent Soriano, Hauke Walter, Jean-Claude Schmit, Anders Sönnerborg, Francesca Ceccherini-Silberstein, Roger Paredes, Andreu de Luca, Andreu de Luca, European recommendations for the clinical use of HIV drug resistance testing: 2011 update Aids Reviews. ,vol. 13, pp. 77- 108 ,(2011)

C. Torti, L. Bono, F. Gargiulo, M.C. Uccelli, E. Quiros-Roldan, A. Patroni, G. Paraninfo, V. Tirelli, N. Manca, M.A. De Francesco, F. Perandin, G. Carosi, Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals Clinical Microbiology and Infection. ,vol. 10, pp. 826- 830 ,(2004) , 10.1111/J.1469-0691.2004.00938.X

Nikolai Mühlberger, Jürgen Wasem, Uwe Siebert, Gaby Sroczynski, Hans Jaeger, Michael Corzillius, Cost effectiveness analysis of routine use of genotypic antiretroviral resistance testing after failure of antiretroviral treatment for HIV Antiviral Therapy. ,vol. 9, pp. 27- 36 ,(2004)

Donato Torre, Roberto Tambini, Antiretroviral drug resistance testing in patients with HIV-1 infection: A meta-analysis study Hiv Clinical Trials. ,vol. 3, pp. 1- 8 ,(2002) , 10.1310/FY66-NVWJ-3332-HW3C

Jean-Luc Meynard, Muriel Vray, Laurence Morand-Joubert, Esther Race, Diane Descamps, Gilles Peytavin, Sophie Matheron, Claire Lamotte, Sonia Guiramand, Dominique Costagliola, Françoise Brun-Vézinet, François Clavel, Pierre-Marie Girard, Narval Trial Group, Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trial. AIDS. ,vol. 16, pp. 727- 736 ,(2002) , 10.1097/00002030-200203290-00008

Javier Ena, Rosa F. Ruiz de Apodaca, Concepción Amador, Concepción Benito, Francisco Pasquau, Net benefits of resistance testing directed therapy compared with standard of care in HIV-infected patients with virological failure: A meta-analysis Enfermedades Infecciosas Y Microbiologia Clinica. ,vol. 24, pp. 232- 237 ,(2006) , 10.1016/S0213-005X(06)73768-5

Cristina Tural, Lidia Ruiz, Christopher Holtzer, Jonathan Schapiro, Pompeyo Viciana, Juan González, Pere Domingo, Charles Boucher, C Rey-Joly, Bonaventura Clotet, Havana Study Group, Clinical utility of HIV-1 genotyping and expert advice: the Havana trial. AIDS. ,vol. 16, pp. 209- 218 ,(2002) , 10.1097/00002030-200201250-00010

Rubeena Ramjan, Alexandra Calmy, Marco Vitoria, Edward J. Mills, Andrew Hill, Graham Cooke, Nathan Ford, Systematic review and meta-analysis: Patient and programme impact of fixed-dose combination antiretroviral therapy Tropical Medicine & International Health. ,vol. 19, pp. 501- 513 ,(2014) , 10.1111/TMI.12297